The "Global Infusion Pumps & Accessories Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Infusion Pumps & Accessories Market size is expected to ...

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...

LONDON, May 16, 2018 /PRNewswire/ -- Global Drug Infusion Systems Market to Reach $14.71 Billion in 2025 The increased prevalence of chronic diseases and the rising geriatric population has led to the ...

Twenty three patients with T1DM, low fasting C-peptide concentrations (<0.20 nmol/l) and intermediate or poor glycaemic control, defined as HbA1c ≥58 mmol/mol and/or ≥5 incidents of hypoglycaemia ...

The US Food and Drug Administration has designated the Eversense (Senseonics, Inc; Ascencia Diabetes Care) implanted continuous glucose monitor (CGM) as an "integrated CGM," meaning it can be used in ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes reported improved quality of life and glycemic control when using a continuous ...

First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...

The market is rapidly advancing, driven by the demand for smaller, more powerful batteries for wearable and remote monitoring ...

NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica ...